IVERIC bio, Inc. (NASDAQ:NASDAQ:ISEE) Q1 2022 Earnings Conference Call May 04, 2022, 08:00 AM ET Company Participants Kathy Galante - SVP of IR Glenn Sblendorio - CEO Pravin Dugel -.
The war has shattered plans for a variety of clinical trials, but Roche is particularly concerned about fenebrutinib, a drug it is developing for multiple sclerosis (MS).